BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effect of Bay Leaves Essential Oil Concentration on the Properties of Biodegradable Carboxymethyl Cellulose-Based Edible Films. ✅
Materials (Basel, Switzerland) (Materials (Basel) ) Vol: 12 Issue 15 Pages: Pub: 2019 Jul 24 Epub: 2019 Jul 24 Authors Rincón E , Serrano L , Balu AM , Aguilar JJ , Luque R , García A , |
|
|
Antioxidant, Anti-Inflammatory, and Microbial-Modulating Activities of Essential Oils: Implications in Colonic Pathophysiology. ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 21 Issue 11 Pages: Pub: 2020 Jun 10 Epub: 2020 Jun 10 Authors Spisni E , Petrocelli G , Imbesi V , Spigarelli R , Azzinnari D , Donati Sarti M , Campieri M , Valerii MC , |
|
|
Eugenol, A Major Component of Clove Oil, Attenuates Adiposity, and Modulates Gut Microbiota in High-Fat Diet-Fed Mice. ✅
Go to Publication ✅
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 66 Issue 20 Pages: e2200387 Pub: 2022 Oct Epub: 2022 Sep 6 Authors Li M , Zhao Y , Wang Y , Geng R , Fang J , Kang SG , Huang K , Tong T , |
|
|
Eugenol, A Major Component of Clove Oil, Attenuates Adiposity, and Modulates Gut Microbiota in High-Fat Diet-Fed Mice. ✅
Go to Publication ✅
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 66 Issue 20 Pages: e2200387 Pub: 2022 Oct Epub: 2022 Sep 6 Authors Li M , Zhao Y , Wang Y , Geng R , Fang J , Kang SG , Huang K , Tong T , |
|
|
Eugenol, A Major Component of Clove Oil, Attenuates Adiposity, and Modulates Gut Microbiota in High-Fat Diet-Fed Mice. ✅
Go to Publication ✅
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 66 Issue 20 Pages: e2200387 Pub: 2022 Oct Epub: 2022 Sep 6 Authors Li M , Zhao Y , Wang Y , Geng R , Fang J , Kang SG , Huang K , Tong T , |
|
|
Eugenol, A Major Component of Clove Oil, Attenuates Adiposity, and Modulates Gut Microbiota in High-Fat Diet-Fed Mice. ✅
Go to Publication ✅
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 66 Issue 20 Pages: e2200387 Pub: 2022 Oct Epub: 2022 Sep 6 Authors Li M , Zhao Y , Wang Y , Geng R , Fang J , Kang SG , Huang K , Tong T , |
|
|
Bactericidal and antioxidant effects of essential oils from Satureja montana L., Myristica fragrans H. and Cymbopogon flexuosus. ✅
Go to Publication ✅
Letters in applied microbiology (Lett Appl Microbiol ) Vol: 74 Issue 5 Pages: 741-751 Pub: 2022 May Epub: 2022 Feb 25 Authors Rezende DADCS , Oliveira CD , Batista LR , Ferreira VRF , Brandão RM , Caetano ARS , Alves MVP , Cardoso MG , |
|
|
Preparation, characterization and antimicrobial activity of inclusion complexes of Myristica fragrans Hott. essential oil in ß-cyclodextrins. ✅
Go to Publication ✅
Die Pharmazie (Pharmazie ) Vol: 74 Issue 10 Pages: 590-594 Pub: 2019 Oct 1 Epub: Authors Wang J , Zhang HH , Liu F , Zhang YP , Zhao YM , |
|
|
Synergistic effect of ampicillin and dihydrobenzofuran neolignans (myticaganal C) identified from the seeds of Myristica fragrans Houtt. against Escherichia coli. ✅
Go to Publication ✅
Journal of advanced pharmaceutical technology & research (J Adv Pharm Technol Res ) Vol: 12 Issue 1 Pages: 79-83 Pub: 2021 Jan-Mar Epub: 2021 Jan 9 Authors Keawchai K , Chumkaew P , Permpoonpattana P , Srisawat T , |
|
|
Isoeugenol has a non-disruptive detergent-like mechanism of action. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 6 Issue Pages: 754 Pub: 2015 Epub: 2015 Jul 28 Authors Hyldgaard M , Mygind T , Piotrowska R , Foss M , Meyer RL , |
|
|
Eugenol alters the integrity of cell membrane and acts against the nosocomial pathogen Proteus mirabilis. ✅
Go to Publication ✅
Archives of pharmacal research (Arch Pharm Res ) Vol: 36 Issue 3 Pages: 282-92 Pub: 2013 Mar Epub: 2013 Feb 27 Authors Devi KP , Sakthivel R , Nisha SA , Suganthy N , Pandian SK , |
|
|
Antibacterial Activity of Myristica fragrans against Oral Pathogens. ✅
Go to Publication ✅
Evidence-based complementary and alternative medicine : eCAM (Evid Based Complement Alternat Med ) Vol: 2012 Issue Pages: 825362 Pub: 2012 Epub: 2012 Aug 28 Authors Shafiei Z , Shuhairi NN , Md Fazly Shah Yap N , Harry Sibungkil CA , Latip J , |
|
|
Arg-gingipain inhibition and anti-bacterial activity selective for Porphyromonas gingivalis by malabaricone C. ✅
Bioscience, biotechnology, and biochemistry (Biosci Biotechnol Biochem ) Vol: 63 Issue 8 Pages: 1475-7 Pub: 1999 Aug Epub: Authors Shinohara C , Mori S , Ando T , Tsuji T , |
|
|
Antimicrobial, synergistic and antibiofilm activities of Myristica fragrans Houtt. Bioactive compounds and their derivatives. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 15 Issue 1 Pages: 33041 Pub: 2025 Sep 26 Epub: 2025 Sep 26 Authors Kaur V , Kaushal S , Kalia A , Jangra R , Sharma P , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
